Related Experiment Video

Updated: Aug 11, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Mantle cell lymphoma

E Vandenberghe1

  • 1University College London Medical School, Dept Haematology, UK.

Blood Reviews
|June 1, 1994
PubMed

Insights

Mantle cell lymphoma (MCL) is a distinct B-cell lymphoma subtype characterized by a specific genetic abnormality. Precise diagnostic criteria and clinical understanding pave the way for targeted treatment protocols for this challenging cancer.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Mantle cell lymphoma (MCL) is a recently defined subtype of non-Hodgkin lymphoma.
  • It originates from the mantle zone of secondary lymphoid follicles and is related to primary B follicles.
  • MCL is classified within diffuse small cleaved cell lymphomas (Working Formulation) and aligns with centrocytic lymphomas (Kiel classification).

Purpose of the Study:

  • To define Mantle Cell Lymphoma (MCL) as a distinct clinico-pathological entity.
  • To highlight the characteristic cytogenetic abnormality associated with MCL.
  • To emphasize the need for developing targeted treatment protocols due to the poor prognosis of MCL patients.

Main Methods:

  • Classification of lymphomas based on established systems (Working Formulation, Kiel classification).
  • Identification of specific cytogenetic abnormalities, including the t(11;14)(q13;q32) translocation.
  • Molecular detection of bcl-1 oncogene rearrangement.

Main Results:

  • MCL represents a distinct clinico-pathological entity.
  • A specific cytogenetic abnormality, t(11;14)(q13;q32), is consistently associated with MCL.
  • This translocation involves the bcl-1 oncogene, detectable at the molecular level.

Conclusions:

  • Mantle cell lymphoma is a unique lymphoma entity with specific diagnostic criteria.
  • The characteristic t(11;14) translocation and bcl-1 oncogene rearrangement are key identifiers.
  • Further research into rational treatment protocols is crucial for improving outcomes in MCL patients with poor prognoses.

More Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...